Oncostatin M-Enriched Small Extracellular Vesicles Derived from Mesenchymal Stem Cells Prevent Isoproterenol-Induced Fibrosis and Enhance Angiogenesis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076467 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sandra Tejedor und 6 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Extracellular Vesicles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, FEDER “una manera de hacer Europa”, Agencia Valenciana de Innovación.
Abstract (Originalsprache)
Myocardial fibrosis is a pathological hallmark of cardiac dysfunction. Oncostatin M (OSM) is a pleiotropic cytokine that can promote fibrosis in different organs after sustained exposure. However, OSM released by macrophages during cardiac fibrosis suppresses cardiac fibroblast activation by modulating transforming growth factor beta 1 (TGF-β1) expression and extracellular matrix deposition. Small extracellular vesicles (SEVs) from mesenchymal stromal cells (MSCs) are being investigated to treat myocardial infarction, using different strategies to bolster their therapeutic ability. Here, we generated TERT-immortalized human MSC cell lines (MSC-T) engineered to overexpress two forms of cleavage-resistant OSM fused to CD81TM (OSM-SEVs), which allows the display of the cytokine at the surface of secreted SEVs. The therapeutic potential of OSM-SEVs was assessed in vitro using human cardiac ventricular fibroblasts (HCF-Vs) activated by TGF-β1. Compared with control SEVs, OSM-loaded SEVs reduced proliferation in HCF-V and blunted telo-collagen expression. When injected intraperitoneally into mice treated with isoproterenol, OSM-loaded SEVs reduced fibrosis, prevented cardiac hypertrophy, and increased angiogenesis. Overall, we demonstrate that the enrichment of functional OSM on the surface of MSC-T-SEVs increases their potency in terms of anti-fibrotic and pro-angiogenic properties, which opens new perspectives for this novel biological product in cell-free-based therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.
- Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 43183 Gothenburg, Sweden.
- Early Cardiovascular Renal and Metabolism (CVRM), Bioscience Cardiovascular, AstraZeneca, 43183 Gothenburg, Sweden.
- GECORP, Av. Juan Manuel de Rosas, Buenos Aires 7220, Argentina.
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Carlos III Institute of Health, 28029 Madrid, Spain.
ORCID-Profile: Hernán González-King, Niek Dekker
Förderung
- Instituto de Salud Carlos III
- FEDER “una manera de hacer Europa”
- Agencia Valenciana de Innovación
- Conselleria de Sanitat Universal i Salut Pública
- European Union
Zitieren
APA
Tejedor, S., Buigues, M., González-King, H., Silva, A. M., García, N. A., Dekker, N., & Sepúlveda, P. (2023). Oncostatin M-Enriched Small Extracellular Vesicles Derived from Mesenchymal Stem Cells Prevent Isoproterenol-Induced Fibrosis and Enhance Angiogenesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076467
Vancouver
Tejedor S, Buigues M, González-King H, Silva AM, García NA, Dekker N, et al. Oncostatin M-Enriched Small Extracellular Vesicles Derived from Mesenchymal Stem Cells Prevent Isoproterenol-Induced Fibrosis and Enhance Angiogenesis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076467
BibTeX
@article{Tejedor2023,
author = {Tejedor, Sandra and Buigues, Marc and González-King, Hernán and Silva, Andreia M and García, Nahuel Aquiles and Dekker, Niek and Sepúlveda, Pilar},
title = {Oncostatin M-Enriched Small Extracellular Vesicles Derived from Mesenchymal Stem Cells Prevent Isoproterenol-Induced Fibrosis and Enhance Angiogenesis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076467}
}
EUVIMED